National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

CDK inhibitor AT7519M (... in-HIH-bih-ter ...)

 A substance being studied in the treatment of some types of cancer. CDK inhibitor AT7519M blocks enzymes needed for cells to divide. It is a type of cyclin-dependent kinase inhibitor. Also called AT7519M.



Previous Definitions:CD134, CD34 antigen, CD4-positive T lymphocyte, CD40-ligand, CDDO
Next Definitions:CEA, CEA assay, cecum, cedarwood, cediranib

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov